![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Bhaskar N. Thorat, Ayantika Sett & A. S. Mujumdar. (2022) Drying of Vaccines and Biomolecules. Drying Technology 40:3, pages 461-483.
Read now
Read now
Huiling Chen, Xuan Ren, Shi Xu, Dekui Zhang & TiYun Han. (2022) Optimization of Lipid Nanoformulations for Effective mRNA Delivery. International Journal of Nanomedicine 17, pages 2893-2905.
Read now
Read now
Khushwant S. Yadav, Archana Upadhya & Ambikanandan Misra. (2021) Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers). Expert Opinion on Drug Delivery 18:1, pages 103-118.
Read now
Read now
Patricia Zancanella, Daniele M. L. Oliveira, Bonald H. de Oliveira, Thiago D. Woiski, Cesar C. Pinto, Maria H. A. Santana, Eliana B. Souto & Patrícia Severino. (2020) Mitotane liposomes for potential treatment of adrenal cortical carcinoma: ex vivo intestinal permeation and in vivo bioavailability. Pharmaceutical Development and Technology 25:8, pages 949-961.
Read now
Read now
Kamel S. Ahmed, Saied A. Hussein, Abdelmoneim H. Ali, Sameh A. Korma, Qiu Lipeng & Chen Jinghua. (2019) Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. Journal of Drug Targeting 27:7, pages 742-761.
Read now
Read now
Vivek Viswanathan, Rajesh Pharande, Anilkumar Bannalikar, Pushpa Gupta, Umesh Gupta & Alka Mukne. (2019) Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies. Drug Development and Industrial Pharmacy 45:1, pages 11-20.
Read now
Read now
Gabriela Garrastazu Pereira, Amanda Jane Lawson, Francesca Buttini & Fabio Sonvico. (2016) Loco-regional administration of nanomedicines for the treatment of lung cancer. Drug Delivery 23:8, pages 2881-2896.
Read now
Read now
Tiffanie Daisy Sugianto & Hak-Kim Chan. (2016) Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives. Expert Opinion on Drug Delivery 13:1, pages 7-22.
Read now
Read now
Anke Saß & Geoffrey Lee. (2014) Evaluation of some water-miscible organic solvents for spray-drying enzymes and carbohydrates. Drug Development and Industrial Pharmacy 40:6, pages 749-757.
Read now
Read now
Ulla Brinkmann-Trettenes, Sabine Barnert & Annette Bauer-Brandl. (2014) Single step bottom-up process to generate solid phospholipid nano-particles. Pharmaceutical Development and Technology 19:3, pages 326-332.
Read now
Read now
Chiraz Jaafar-Maalej, Abdelhamid Elaissari & Hatem Fessi. (2012) Lipid-based carriers: manufacturing and applications for pulmonary route. Expert Opinion on Drug Delivery 9:9, pages 1111-1127.
Read now
Read now
Articles from other publishers (60)
Anubhav Pratap-Singh, Yigong Guo, Alberto Baldelli & Anika Singh. (2023) Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs. Pharmaceutics 15:9, pages 2265.
Crossref
Crossref
Bo Wang, Jia Xiang, Binsheng He, Songwen Tan & Wenhu Zhou. (2023) Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: technological advancements and future directions. Frontiers in Nutrition 10.
Crossref
Crossref
Jana Szabová, Ondrej Mišík, Jan Fučík, Kateřina Mrázová, Ludmila Mravcová, Jakub Elcner, František Lízal, Vladislav Krzyžánek & Filip Mravec. (2023) Liposomal form of erlotinib for local inhalation administration and efficiency of its transport to the lungs. International Journal of Pharmaceutics 634, pages 122695.
Crossref
Crossref
Jana Szabová, Filip Mravec, Mostafa Mokhtari, Rémi Le Borgne, Michal Kalina & Jean-François Berret. (2023) N,N,N-Trimethyl chitosan as a permeation enhancer for inhalation drug delivery: Interaction with a model pulmonary surfactant. International Journal of Biological Macromolecules, pages 124235.
Crossref
Crossref
MANSING PATIL & PINKAL PATEL. (2023) LIPOSOMAL DRY POWDER INHALER: NOVEL PULMONARY TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF LUNG CANCER. International Journal of Applied Pharmaceutics, pages 1-12.
Crossref
Crossref
Yanan Meng, Xia Niu & Guiling Li. (2023) Liposome Nanoparticles as a Novel Drug Delivery System for Therapeutic
and Diagnostic Applications. Current Drug Delivery 20:1, pages 41-56.
Crossref
Crossref
Chetna Gupta, Aadya Jaipuria & Nikesh Gupta. (2022) Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments. Pharmaceutics 15:1, pages 139.
Crossref
Crossref
Jing Chen, Yuan Lin, Min Wu, Chuangnan Li, Kaijie Cen, Fujin Liu, Yazhi Liao, Xiaoqing Zhou, Jucai Xu & Yi Cheng. (2022) Glycyrrhetinic acid proliposomes mediated by mannosylated ligand: Preparation, physicochemical characterization, environmental stability and bioactivity evaluation. Colloids and Surfaces B: Biointerfaces 218, pages 112781.
Crossref
Crossref
Zahra Ghaemmaghamian, Reza Zarghami, Gavin Walker, Emmet O’Reilly & Ahmad Ziaee. (2022) Stabilizing vaccines via drying: Quality by design considerations. Advanced Drug Delivery Reviews 187, pages 114313.
Crossref
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Crossref
Khaled AboulFotouh, Haiyue Xu, Chaeho Moon, Robert O. WilliamsIIIIII & Zhengrong Cui. (2022) Development of (Inhalable) Dry Powder Formulations of AS01B-Containing Vaccines Using Thin-Film Freeze-Drying. International Journal of Pharmaceutics 622, pages 121825.
Crossref
Crossref
Benedikt C. Huck, Durairaj Thiyagarajan, Aghiad Bali, Annette Boese, Karen F. W. Besecke, Constantin Hozsa, Robert K. Gieseler, Marcus Furch, Cristiane Carvalho‐Wodarz, Franziska Waldow, Dominik Schwudke, Olga Metelkina, Alexander Titz, Hanno Huwer, Konrad Schwarzkopf, Jessica Hoppstädter, Alexandra K. Kiemer, Marcus Koch, Brigitta Loretz & Claus‐Michael Lehr. (2022) Nano‐in‐Microparticles for Aerosol Delivery of Antibiotic‐Loaded, Fucose‐Derivatized, and Macrophage‐Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. Advanced Healthcare Materials 11:11.
Crossref
Crossref
Clarinda Costa, Beatriz Nobre, Ana Sofia Matos, Ana Sofia Silva, Teresa Casimiro, Maria Luísa Corvo & Ana Aguiar-Ricardo. (2021) Inhalable hydrophilic molecule-loaded liposomal dry powder formulations using supercritical CO2 – assisted spray-drying. Journal of CO2 Utilization 53, pages 101709.
Crossref
Crossref
Jana Szabová, Ondrej Mišík, Martina Havlíková, František Lízal & Filip Mravec. (2021) Influence of liposomes composition on their stability during the nebulization process by vibrating mesh nebulizer. Colloids and Surfaces B: Biointerfaces 204, pages 111793.
Crossref
Crossref
Li Ding, Jieliang Wang, Shihao Cai, Hugh Smyth & Zhengrong Cui. (2021) Pulmonary biofilm-based chronic infections and inhaled treatment strategies. International Journal of Pharmaceutics 604, pages 120768.
Crossref
Crossref
Manal AlmalkiEdward P.C. LaiRaymond KoChunsheng Li. (2021) Facile preparation of liposome-encapsulated Zn–DTPA from soy lecithin for decorporation of radioactive actinides. Canadian Journal of Chemistry 99:6, pages 540-548.
Crossref
Crossref
Ramachandran Chelliah, Imran Khan, Eric Banan-Mwine Daliri, L. Tamizhini, K. S. Pravitha, Mahamuda Begum, Kandasamy Saravanakumar, Myeong-Hyeon Wang & Deog Hwan Oh. 2021. Smart Nanomaterials in Biomedical Applications. Smart Nanomaterials in Biomedical Applications
425
447
.
Maryam Farzan, Gabriela Québatte, Katrin Strittmatter, Florentine Marianne Hilty, Joachim Schoelkopf, Jörg Huwyler & Maxim Puchkov. (2020) Spontaneous In Situ Formation of Liposomes from Inert Porous Microparticles for Oral Drug Delivery. Pharmaceutics 12:8, pages 777.
Crossref
Crossref
Tongtong Zhang, Rui Wang, Miao Li, Jianwei Bao, Yanming Chen, Yuanyuan Ge & Yiguang Jin. (2020) Comparative study of intratracheal and oral gefitinib for the treatment of primary lung cancer. European Journal of Pharmaceutical Sciences 149, pages 105352.
Crossref
Crossref
Piyush P. Mehta, Debjit Ghoshal, Atmaram P. Pawar, Shivajirao S. Kadam & Vividha S. Dhapte-Pawar. (2020) Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance. Journal of Drug Delivery Science and Technology 56, pages 101509.
Crossref
Crossref
Isra Khatib, Patricia Tang, Juanfang Ruan, David Cipolla, Francis Dayton, James D. Blanchard & Hak-Kim Chan. (2020) Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation. International Journal of Pharmaceutics 578, pages 119045.
Crossref
Crossref
Varsha Komalla & Mehra Haghi. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
375
392
.
Cecilia Velino, Francesca Carella, Alessio Adamiano, Maurizio Sanguinetti, Alberto Vitali, Daniele Catalucci, Francesca Bugli & Michele Iafisco. (2019) Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Crossref
Yuwei Wang & David W. Grainger. (2019) Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments. Advanced Drug Delivery Reviews 151-152, pages 56-71.
Crossref
Crossref
Isra Khatib, Dipesh Khanal, Juanfang Ruan, David Cipolla, Francis Dayton, James D. Blanchard & Hak-Kim Chan. (2019) Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation. International Journal of Pharmaceutics 566, pages 641-651.
Crossref
Crossref
Riccardo V. D'Elia, Stuart Woods, Wendy Butcher, Jonathan McGahon, Swapnil Khadke, Yvonne Perrie, E. Diane Williamson & Craig W. Roberts. (2019) Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments. Journal of Controlled Release 298, pages 202-212.
Crossref
Crossref
Tingting Liu, Wenquan Zhu, Cuiyan Han, Xiaoyu Sui, Chang Liu, Xiaoxing Ma & Yan Dong. (2018) Preparation of Glycyrrhetinic Acid Liposomes Using Lyophilization Monophase Solution Method: Preformulation, Optimization, and In Vitro Evaluation. Nanoscale Research Letters 13:1.
Crossref
Crossref
Silvia Franzé, Francesca Selmin, Elena Samaritani, Paola Minghetti & Francesco Cilurzo. (2018) Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics 10:3, pages 139.
Crossref
Crossref
Tingting Liu, Meihua Han, Fang Tian, Dongmei Cun, Jukka Rantanen & Mingshi Yang. (2018) Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: In vitro and in vivo evaluation. Carbohydrate Polymers 181, pages 1143-1152.
Crossref
Crossref
S. Chennakesavulu, A. Mishra, A. Sudheer, C. Sowmya, C. Suryaprakash Reddy & E. Bhargav. (2018) Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis. Asian Journal of Pharmaceutical Sciences 13:1, pages 91-100.
Crossref
Crossref
I. M. Le-Deygen, A. A. Skuredina & E. V. Kudryashova. (2017) Drug delivery systems for fluoroquinolones: New prospects in tuberculosis treatment. Russian Journal of Bioorganic Chemistry 43:5, pages 487-501.
Crossref
Crossref
Abel M. Maharramov, Mahammadali A. Ramazanov & Ulviyya A. Hasanova. 2017. Antimicrobial Nanoarchitectonics. Antimicrobial Nanoarchitectonics
445
473
.
David Cipolla. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery
151
174
.
Ralph Tripp & Jarod Hanson. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery
93
130
.
Zahra Kakhi, Benoît Frisch, Béatrice Heurtault & Françoise Pons. (2016) Liposomal constructs for antitumoral vaccination by the nasal route. Biochimie 130, pages 14-22.
Crossref
Crossref
Thaigarajan Parumasivam, Rachel Yoon Kyung Chang, Sharif Abdelghany, Tian Tian Ye, Warwick John Britton & Hak-Kim Chan. (2016) Dry powder inhalable formulations for anti-tubercular therapy. Advanced Drug Delivery Reviews 102, pages 83-101.
Crossref
Crossref
Zahra Kakhi, Benoît Frisch, Line Bourel-Bonnet, Joseph Hemmerlé, Françoise Pons & Béatrice Heurtault. (2015) Airway administration of a highly versatile peptide-based liposomal construct for local and distant antitumoral vaccination. International Journal of Pharmaceutics 496:2, pages 1047-1056.
Crossref
Crossref
Jeffry G. Weers & Danforth P. Miller. (2015) Formulation Design of Dry Powders for Inhalation. Journal of Pharmaceutical Sciences 104:10, pages 3259-3288.
Crossref
Crossref
Yahya Rahimpour, Hamed Hamishehkar & Ali Nokhodchi. 2015. Pulmonary Drug Delivery. Pulmonary Drug Delivery
123
142
.
Zhenglin Liang, Rui Ni, Jieyu Zhou & Shirui Mao. (2015) Recent advances in controlled pulmonary drug delivery. Drug Discovery Today 20:3, pages 380-389.
Crossref
Crossref
Ye Li, Xianren Zhang & Dapeng Cao. (2015) Nanoparticle hardness controls the internalization pathway for drug delivery. Nanoscale 7:6, pages 2758-2769.
Crossref
Crossref
Peipei Guan, Yi Lu, Jianping Qi, Mengmeng Niu, Ruyue Lian & Wei Wu. (2015) Solidification of liposomes by freeze-drying: The importance of incorporating gelatin as interior support on enhanced physical stability. International Journal of Pharmaceutics 478:2, pages 655-664.
Crossref
Crossref
Dinh-Duy Pham, Elias Fattal & Nicolas Tsapis. (2015) Pulmonary drug delivery systems for tuberculosis treatment. International Journal of Pharmaceutics 478:2, pages 517-529.
Crossref
Crossref
Željka Vanić, Odon Planinšek, Nataša Škalko-Basnet & Ingunn Tho. (2014) Tablets of pre-liposomes govern in situ formation of liposomes: Concept and potential of the novel drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics 88:2, pages 443-454.
Crossref
Crossref
Silvia F. Pantze, Johannes Parmentier, Götz Hofhaus & Gert Fricker. (2014) Matrix liposomes: A solid liposomal formulation for oral administration. European Journal of Lipid Science and Technology 116:9, pages 1145-1154.
Crossref
Crossref
David McClements. 2014. Nanoparticle- and Microparticle-based Delivery Systems. Nanoparticle- and Microparticle-based Delivery Systems
401
452
.
Ivana d'Angelo, Claudia Conte, Maria Immacolata La Rotonda, Agnese Miro, Fabiana Quaglia & Francesca Ungaro. (2014) Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies. Advanced Drug Delivery Reviews 75, pages 92-111.
Crossref
Crossref
M. Hoppentocht, P. Hagedoorn, H.W. Frijlink & A.H. de Boer. (2014) Technological and practical challenges of dry powder inhalers and formulations. Advanced Drug Delivery Reviews 75, pages 18-31.
Crossref
Crossref
Misagh Alipour & Zacharias E Suntres. (2014)
Liposomal antibiotic formulations for targeting the lungs in the treatment of
Pseudomonas aeruginosa
. Therapeutic Delivery 5:4, pages 409-427.
Crossref
Crossref
Frank BoehmMisagh Alipour, Abdelwahab Omri & Zacharias Suntres. 2013. Nanomedical Device and Systems Design. Nanomedical Device and Systems Design
455
490
.
David CipollaIgor Gonda & Hak-Kim Chan. (2013) Liposomal formulations for inhalation. Therapeutic Delivery 4:8, pages 1047-1072.
Crossref
Crossref
Lauren Willis, Don HayesJr.Jr. & Heidi M. Mansour. (2012) Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery. Lung 190:3, pages 251-262.
Crossref
Crossref
Heidi M. Mansour, Yun-Seok Rhee, Chun-Woong Park & Patrick P. DeLuca. 2012. Lipids in Nanotechnology. Lipids in Nanotechnology
221
268
.
Ae Jung Huh & Young Jik Kwon. (2011) “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Journal of Controlled Release 156:2, pages 128-145.
Crossref
Crossref
Ken-Ichi Izutsu, Chikako Yomota & Toru Kawanishi. (2011) Stabilization of Liposomes in Frozen Solutions Through Control of Osmotic Flow and Internal Solution Freezing by Trehalose. Journal of Pharmaceutical Sciences 100:7, pages 2935-2944.
Crossref
Crossref
L. Lesoin, C. Crampon, O. Boutin & E. Badens. (2011) Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method. The Journal of Supercritical Fluids 57:2, pages 162-174.
Crossref
Crossref
John Cannon. 2011. Drug Delivery Systems, Third Edition. Drug Delivery Systems, Third Edition
305
371
.
Jeffry G. WeersJohn BellHak-Kim ChanDavid CipollaCraig DunbarAnthony J. HickeyIan J. Smith. (2010) Pulmonary Formulations: What Remains to be Done?. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23:S2, pages S-5-S-23.
Crossref
Crossref
Aileen Gibbons, Noel G. McElvaney & Sally-Ann Cryan. (2010) A Dry Powder Formulation of Liposome-Encapsulated Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) for Inhalation: Preparation and Characterisation. AAPS PharmSciTech 11:3, pages 1411-1421.
Crossref
Crossref
Ri Hua Li, Seung-Yong Seo, Jae-Soon Eun & Mi-Kyung Lee. (2010) Preparation and Evaluation of Freeze-dried Solid Lipid Nanoparticles with Various Cryoprotectants. Journal of Korean Pharmaceutical Sciences 40:1, pages 39-43.
Crossref
Crossref